Survodutide is an investigational dual GLP-1/glucagon receptor agonist under active evaluation for metabolic dysfunction-associated steatohepatitis (MASH).
Read more Survodutide in MASH Research: Clinical Evidence and Hepatic Mechanisms
Survodutide in MASH Research: Clinical Evidence and Hepatic Mechanisms